Behrod Philip Alinejad, PMHNP-BC
Psychiatric/Mental Health · Calabasas
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Behrod Philip Alinejad’s office at (855) 247-2778 to ask if they take your plan before you enroll.
Medicaid work
$16,153 in 2024
Medicaid paid $16,153 for 58 billed services this clinician did in 2024, up to 20 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 58 | $16,153 |
| 2024 | 58 | 1 | 20 | $16,153 |
Drugs they prescribed that Part D paid
$236
Pharmacies billed $236 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 23) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
23 generic and 0 brand-name prescriptions · $236 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Money from drug and device companies
$1,568 in 2025
| 2025 | 9 | 46 | None | $1,568 |
| 2024 | 5 | 13 | None | $414 |
| 2022 | 1 | 1 | None | $22 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Vraylar | $938 | 29 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $199 | 4 payments
|
| Otsuka America Pharmaceutical | Rexulti | $167 | 3 payments
|
| Alkermes | Aristada | $70 | 3 payments
|
| Bausch Health US | Aplenzin | $62 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Cobenfy | $42 | 1 payment
|
See all 46 published payments
| E.R. Squibb & Sons L.L.C. | Meals · 2025-12-17 | Cobenfy | $42 |
| Abbvie | Meals · 2025-12-17 | Vraylar | $23 |
| Abbvie | Meals · 2025-12-16 | Vraylar | $25 |
| Abbvie | Meals · 2025-12-10 | Vraylar | $25 |
| Abbvie | Meals · 2025-11-19 | Vraylar | $26 |
| Abbvie | Meals · 2025-11-19 | Vraylar | $10 |
| Alkermes | Meals · 2025-11-12 | Aristada | $22 |
| Otsuka America Pharmaceutical | Meals · 2025-11-11 | Rexulti | $122 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-10-30 | Caplyta | $110 |
| Abbvie | Meals · 2025-10-15 | Vraylar | $18 |
| Otsuka America Pharmaceutical | Meals · 2025-10-09 | Rexulti | $23 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-09-24 | Caplyta | $31 |
| Alkermes | Meals · 2025-09-18 | Aristada | $26 |
| Abbvie | Meals · 2025-09-03 | Vraylar | $25 |
| Neos Therapeutics LP | Meals · 2025-08-27 | Adzenys Xr-Odt | $22 |
| Abbvie | Meals · 2025-08-26 | Vraylar | $30 |
| Otsuka America Pharmaceutical | Meals · 2025-08-20 | Rexulti | $23 |
| Bausch Health US | Meals · 2025-08-19 | Aplenzin | $22 |
| Abbvie | Meals · 2025-08-13 | Vraylar | $25 |
| Abbvie | Meals · 2025-08-11 | Vraylar | $24 |
| Abbvie | Meals · 2025-08-07 | Vraylar | $125 |
| Abbvie | Meals · 2025-08-06 | Vraylar | $26 |
| Abbvie | Meals · 2025-07-29 | Vraylar | $32 |
| Abbvie | Meals · 2025-07-22 | Vraylar | $32 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-07-16 | Caplyta | $26 |
| Abbvie | Meals · 2025-07-15 | Vraylar | $33 |
| Lundbeck | Meals · 2025-07-10 | Rexulti | $26 |
| Abbvie | Meals · 2025-07-09 | Vraylar | $26 |
| Alkermes | Meals · 2025-07-02 | Aristada | $23 |
| Abbvie | Meals · 2025-06-17 | Vraylar | $31 |
| Janssen Pharmaceuticals | Meals · 2025-06-11 | Spravato | $41 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-05-22 | Caplyta | $32 |
| Abbvie | Meals · 2025-05-20 | Vraylar | $26 |
| Abbvie | Meals · 2025-05-14 | Vraylar | $7 |
| Abbvie | Meals · 2025-05-14 | Vraylar | $28 |
| Bausch Health US | Meals · 2025-05-05 | Aplenzin | $24 |
| Abbvie | Meals · 2025-04-24 | Vraylar | $33 |
| Abbvie | Meals · 2025-04-17 | Vraylar | $20 |
| Abbvie | Meals · 2025-04-09 | Vraylar | $27 |
| Abbvie | Meals · 2025-03-13 | Vraylar | $26 |
| Bausch Health US | Meals · 2025-03-13 | Aplenzin | $16 |
| Abbvie | Meals · 2025-03-04 | Vraylar | $33 |
| Abbvie | Meals · 2025-03-04 | Vraylar | $32 |
| Abbvie | Meals · 2025-02-27 | Vraylar | $113 |
| Abbvie | Meals · 2025-02-20 | Vraylar | $32 |
| Abbvie | Meals · 2025-02-03 | Vraylar | $25 |
See earlier years (2024, 2022)
2024: $414
| Abbvie | Vraylar | $179 | 7 payments
|
| Idorsia Pharmaceuticals US | Quviviq | $119 | 1 payment
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $60 | 2 payments
|
| Almatica Pharma | Loreev Xr | $36 | 2 payments
|
| Otsuka America Pharmaceutical | Rexulti | $20 | 1 payment
|
2022: $22
| Boston Scientific | Watchman Access System | $22 | 1 payment
|
Professional record
- NPI
- 1497471825
- Licence
- CA 95021186
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LP0808X (363LP0808X)
- Mailing address
- 3835 N Freeway Blvd Ste 100, Sacramento, CA, 95834
- NPI first listed
- 2022-10-17
- NPI last updated
- 2024-02-22
- NPI record certified
- 2024-02-22
This is when the NPI record was last certified, not a medical board exam.